Saniona Logo

Saniona

Develops ion channel medicines for rare neurological diseases and epilepsy.

SANION | ST

Overview

Corporate Details

ISIN(s):
SE0005794617 (+1 more)
LEI:
549300XO4L9XNOCFCZ84
Country:
Denmark
Address:
Smedeland 26 B, 2600 GLOSTRUP
Sector:
Mining and quarrying
Industry:
Mining of non-ferrous metal ores

Description

Saniona is a clinical-stage biopharmaceutical company specializing in the discovery and development of proprietary medicines for rare diseases. A pioneer in ion channel research, the company leverages its expertise in highly specific ion channel modulation to develop treatments for neurological and psychiatric disorders, with a key focus on epilepsy. Saniona operates a robust drug discovery engine supported by a proprietary library of over 20,000 molecules, advancing a pipeline of potential new medicines through clinical trials to address high unmet medical needs.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-09-04 08:00
Regulatory News Service
Saniona väljer SAN2668 som först-i-klassen klinisk kandidat för pediatrisk epil…
Swedish 220.1 KB
2025-09-04 08:00
Regulatory News Service
Saniona selects SAN2668 as first-in-class clinical candidate for paediatric epi…
English 218.7 KB
2025-08-28 08:00
Interim Report
Swedish 1.2 MB
2025-08-28 08:00
Interim Report
English 1.1 MB
2025-08-20 13:30
M&A Activity
Saniona ingår exklusivt licensavtal med Jazz Pharmaceuticals för att utveckla o…
Swedish 232.7 KB
2025-08-20 13:30
M&A Activity
Saniona Enters Exclusive Licensing Agreement with Jazz Pharmaceuticals to Devel…
English 233.7 KB
2025-07-31 08:00
Declaration of Voting Results & Voting Rights Announcements
Ändring av antalet aktier och röster i Saniona AB
Swedish 151.7 KB
2025-07-31 08:00
Declaration of Voting Results & Voting Rights Announcements
Change in number of shares and votes in Saniona AB
English 150.7 KB
2025-06-26 17:30
Share Issue/Capital Change
Fenja Capital II A/S requests conversion of the remaining outstanding convertib…
English 146.1 KB
2025-06-26 17:30
Share Issue/Capital Change
Fenja Capital II A/S påkallar konvertering av resterande utestående konvertible…
Swedish 146.6 KB
2025-05-28 17:05
Post-Annual General Meeting Information
Kommuniké från årsstämma den 28 maj 2025 i Saniona AB
Swedish 216.1 KB
2025-05-28 17:05
Post-Annual General Meeting Information
Bulletin from the Saniona AB annual shareholders’ meeting on May 28, 2025
English 216.0 KB
2025-05-28 08:00
Earnings Release
Swedish 1.2 MB
2025-05-28 08:00
Investor Presentation
English 1.1 MB
2025-05-12 08:00
Board/Management Information
Saniona utser Johnny Stilou till Chief Financial Officer
Swedish 210.3 KB

Automate Your Workflow. Get a real-time feed of all Saniona filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Saniona via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
2025-04-01 Thomas Feldthus Other Other 220,000 1,073,600.00 SEK
2025-04-01 Pierandrea Muglia Other Other 53,333 260,265.04 SEK
2025-04-01 Thomas Feldthus Other Other 30,000 146,400.00 SEK
2024-10-02 John Haurum Other Buy 67,100 60,363.16 SEK
2024-10-02 John Haurum Other Buy 12,361 51,415.58 SEK
2024-01-29 Pierandrea Muglia Other Other 53,333 219,731.96 SEK
2022-07-05 Karl Johan Bertil Sundberg Other Buy 40,000 142,128.00 SEK
2022-07-05 Thomas Feldthus Other Buy 30,000 130,590.00 SEK
2022-07-05 Thomas Feldthus Other Buy 30,000 129,600.00 SEK
2022-07-05 Thomas Feldthus Other Buy 5,221 22,685.24 SEK

Peer Companies

Company Country Ticker View
Isofol Medical Logo
Developing a drug to enhance chemotherapy efficacy for solid tumors like colorectal cancer.
Sweden ISOFOL
B2B platform for Ukraine-Korea trade, investment, and post-war reconstruction.
South Korea 052770
IVISIONWORKS CO.,LTD. Logo
Accelerates social impact startups & develops digital therapeutics for cognitive rehabilitation.
South Korea 469750
A diversified, Asia-focused conglomerate with businesses in property, retail, auto, and more.
Bermuda N/A
The world's largest uranium producer, managing the front-end of the global nuclear fuel cycle.
Kazakhstan N/A
KAINOS MEDICINE, INC. Logo
Develops small molecule drugs for neurodegenerative diseases, cancers, and infectious diseases.
South Korea 284620
Kanamoto Co., Ltd. Logo
Global provider of rental construction equipment, also selling used machinery and steel products.
Japan 9678
Keihan Holdings Co.,Ltd. Logo
A conglomerate integrating transport, real estate, and retail for regional development.
Japan 9045
KNT-CT Holdings Co.,Ltd. Logo
A travel holding company offering themed tours and corporate travel solutions to boost Japan tourism.
Japan 9726
KoBioLabs, Inc. Logo
Develops AI-driven microbiome therapeutics for immune, metabolic, and brain disorders.
South Korea 348150

Talk to a Data Expert

Have a question? We'll get back to you promptly.